Envestnet Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Buy
105,333
+10,800
+11% +$3.11M 0.01% 1091
2025
Q4
$28.6M Sell
94,533
-13,220
-12% -$4.13M 0.01% 1020
2025
Q3
$30.2M Buy
107,753
+4,351
+4% +$1.18M 0.01% 1037
2025
Q2
$25M Buy
103,402
+178
+0.2% +$42.1K 0.01% 1118
2025
Q1
$25.1M Sell
103,224
-1,803
-2% -$542K 0.01% 1053
2024
Q4
$34.5M Buy
105,027
+6,287
+6% +$2.13M 0.01% 872
2024
Q3
$33M Sell
98,740
-10,311
-9% -$3.27M 0.01% 919
2024
Q2
$29.8M Buy
109,051
+9,185
+9% +$2.67M 0.01% 907
2024
Q1
$34.5M Sell
99,866
-2,112
-2% -$695K 0.01% 827
2023
Q4
$32.9M Sell
101,978
-68,251
-40% -$21.4M 0.01% 788
2023
Q3
$61M Buy
170,229
+55,233
+48% +$21.3M 0.03% 503
2023
Q2
$43.6M Buy
114,996
+5,761
+5% +$2.34M 0.02% 572
2023
Q1
$52.3M Buy
109,235
+5,223
+5% +$2.44M 0.03% 486
2022
Q4
$43.7M Buy
104,012
+13,062
+14% +$5.27M 0.02% 524
2022
Q3
$37.9M Buy
90,950
+9,551
+12% +$4.76M 0.02% 521
2022
Q2
$40.3M Buy
81,399
+8,023
+11% +$4.18M 0.02% 511
2022
Q1
$41.3M Buy
73,376
+5,036
+7% +$3.04M 0.02% 544
2021
Q4
$51.6M Buy
68,340
+7,878
+13% +$5.9M 0.03% 487
2021
Q3
$45.1M Buy
60,462
+3,990
+7% +$2.99M 0.02% 487
2021
Q2
$36.4M Buy
56,472
+4,595
+9% +$2.8M 0.02% 556
2021
Q1
$29.6M Buy
51,877
+7,610
+17% +$4.51M 0.02% 576
2020
Q4
$25.8M Buy
44,267
+362
+0.8% +$206K 0.02% 545
2020
Q3
$22.6M Buy
43,905
+1,072
+3% +$543K 0.02% 510
2020
Q2
$19.3M Buy
42,833
+6,414
+18% +$2.83M 0.02% 536
2020
Q1
$12.8M Buy
36,419
+4,614
+15% +$1.7M 0.02% 589
2019
Q4
$11.8M Buy
31,805
+12,067
+61% +$4.25M 0.01% 735
2019
Q3
$6.57M Buy
19,738
+1,872
+10% +$611K 0.01% 939
2019
Q2
$5.58M Buy
17,866
+1,920
+12% +$575K 0.01% 992
2019
Q1
$4.87M Buy
15,946
+2,905
+22% +$784K 0.01% 1003
2018
Q4
$3.03M Buy
+13,041
New +$3.5M ﹤0.01% 1127
2018
Q3
Sell
-2,317
Closed -$668K 1382
2018
Q2
$668K Sell
2,317
-7
-0.3% -$1.93K ﹤0.01% 1202
2018
Q1
$581K Sell
2,324
-2,693
-54% -$686K ﹤0.01% 1152
2017
Q4
$1.2M Sell
5,017
-30
-0.6% -$7.27K ﹤0.01% 1139
2017
Q3
$1.12M Sell
5,047
-119
-2% -$26.8K ﹤0.01% 1122
2017
Q2
$1.17M Sell
5,166
-49
-0.9% -$10.7K ﹤0.01% 1111
2017
Q1
$1.04M Sell
5,215
-100
-2% -$19.3K ﹤0.01% 1208
2016
Q4
$970K Buy
5,315
+299
+6% +$51K ﹤0.01% 1197
2016
Q3
$822K Sell
5,016
-2,145
-30% -$326K ﹤0.01% 1343
2016
Q2
$1.02M Sell
7,161
-154
-2% -$22K ﹤0.01% 1323
2016
Q1
$1M Sell
7,315
-356
-5% -$46.7K ﹤0.01% 1308
2015
Q4
$1.06M Sell
7,671
-534
-7% -$74K ﹤0.01% 1253
2015
Q3
$1.1M Sell
8,205
-234
-3% -$33.7K 0.01% 1232
2015
Q2
$1.27M Sell
8,439
-39
-0.5% -$5.58K 0.01% 1281
2015
Q1
$1.15M Buy
8,478
+8,270
+3,976% +$1.03M 0.01% 1236
2014
Q4
$25K Buy
208
+43
+26% +$4.95K ﹤0.01% 1664
2014
Q3
$19K Buy
165
+37
+29% +$4.38K ﹤0.01% 1897
2014
Q2
$15K Buy
128
+66
+106% +$8.06K ﹤0.01% 1859
2014
Q1
$8K Buy
62
+6
+11% +$769 ﹤0.01% 1955
2013
Q4
$7K Hold
56
﹤0.01% 1868
2013
Q3
$7K Sell
56
-19
-25% -$2.24K ﹤0.01% 1808
2013
Q2
$8K Buy
+75
New +$8.8K ﹤0.01% 1735

Other funds holding BIO